Medtronic PLC vs Wheaton Precious Metals Corp — how do they compare? Medtronic PLC trades at $82.57 (market cap $106.61B), while Wheaton Precious Metals Corp trades at $109.59 (market cap $46.54B). The key difference: Medtronic PLC is far larger — about 2.3× Wheaton Precious Metals Corp's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | WPM | |
|---|---|---|
Market Cap | $106.61B | $46.54B |
Sector | Health | Basic Materials |
52-Week High | $105.35 | $165.72 |
52-Week Low | $73.75 | $91.00 |
Enterprise Value | $125.36B | $44.39B |
Dividend Yield | 3.46% | 0.75% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Wheaton Precious Metals (WPM) trades at $103.81, down 0.36% today, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.28 exceeding the $1.24 estimate. Revenue surged to $2.31 billion in 2025, driving a net income margin of 63.58%. Operating cash flow reached a record $1.90 billion, supporting a positive net cash flow of $335.43 million. Analyst consensus remains strongly bullish with an 80% buy rating and a $161.75 price target, indicating significant upside potential.
WPM presents a compelling investment case based on robust fundamentals and strong analyst support, though technical indicators suggest near-term caution. Key opportunities include sustained earnings growth, high profit margins, and a solid cash flow outlook. Risks involve exposure to precious metal price volatility, geopolitical tensions impacting mining operations, and potential valuation compression if silver prices remain subdued. The stock's current price offers an attractive entry point relative to analyst targets, but investors should monitor commodity market trends and quarterly performance closely.
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →